Back
Actinium Pharmaceuticals Stock Price Chart

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Buy
52
ATNM
Actinium Pharmaceuticals
Last Price:
$1.67
Seasonality Move:
-8.36%
7 Day Trial
ALL ACCESS PASS
$
7

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
The current trend is moderately bullish and ATNM is experiencing slight buying pressure.
Actinium Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.63 | Buy |
20-day SMA: | 1.51 | Buy |
50-day SMA: | 1.43 | Buy |
200-day SMA: | 1.52 | Buy |
8-day EMA: | 1.65 | Buy |
20-day EMA: | 1.54 | Buy |
50-day EMA: | 1.44 | Buy |
200-day EMA: | 2.23 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 60.91 | Buy |
Chaikin Money Flow: | 103745 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.63) | Buy |
Bollinger Bands (100): | (1.13 - 1.51) | Buy |
Actinium Pharmaceuticals Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.71 while ATNM 8-day simple moving average is 1.63, which is a Buy signal.
-
The stock price of ATNM is 1.71 while Actinium Pharmaceuticals 20-day SMA is 1.51, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day simple moving average is 1.43 while ATNM share price is 1.71, making it a Buy technically.
-
ATNM stock price is 1.71 and Actinium Pharmaceuticals 200-day simple moving average is 1.52, creating a Buy signal.
ATNM Technical Analysis vs Fundamental Analysis
Buy
52
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a BuyThe current Actinium Pharmaceuticals [ATNM] share price is $1.71. The Score for ATNM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
53.3M
Price in USD:
1.71
Share Volume:
363.1K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
8.81
52-Week Low:
1.03
Buy
52
Actinium Pharmaceuticals (ATNM)
is a Buy
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?The Actinium Pharmaceuticals stock price is 1.71 USD today.
-
Will ATNM stock go up or go down?Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Actinium Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is not overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.71 while ATNM 8-day exponential moving average is 1.65, which is a Buy signal.
-
The stock price of ATNM is 1.71 while Actinium Pharmaceuticals 20-day EMA is 1.54, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day exponential moving average is 1.44 while ATNM share price is 1.71, making it a Buy technically.
-
ATNM stock price is 1.71 and Actinium Pharmaceuticals 200-day simple moving average is 2.23, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.68 per share, a decrease this year of $0.06 per share, and an increase next year of $0.71 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
-
ATNM Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Actinium Pharmaceuticals is a Buy
-
Actinium Pharmaceuticals Relative Strength Index (RSI) is 60.91, which suggest Actinium Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.29 - 1.63), which suggest Actinium Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Actinium Pharmaceuticals is (1.13 - 1.51), which suggest Actinium Pharmaceuticals is a Buy
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.